A Tiny Biotech Just Posted 10× Stronger Cancer Results

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Stock Of The Day: Is Pfizer Set Up To Rally?

Mark Putrino
November 15, 2024

Pfizer Inc. (NYSE:PFE) shares are lower on Thursday due to news that President-elect Donald Trump picked Robert F. Kennedy Jr. as his next secretary of the Department of Health and Human Services. This has some investors concerned because Kennedy was critical of certain vaccines and vaccinations.

Some believe the weakness in the stock may present a buying opportunity. This is why our team of expert traders and technical analysts has made it our Stock of the Day.

On Wall Street, many trading strategies and methods are based on the concept of reversion to the mean. If something goes too far one way, there is a good chance that it reverses and comes back the other way.

Most of the time, a stock stays in what is known as its trading range. But sometimes investors and traders can become emotional and aggressive. They can push the shares out of the range.

When this happens, there may be opportunities to profit. There is a good chance there will be a reversion back to the mean.

Read Also: WHO Calls Vaccines ‘Absolutely Critical’ As Trump’s Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill

If a stock is below its typical or average range, traders say that it is “oversold.” Some anticipate a reversal back to the average. This would mean a move higher.

So, they enter the market as buyers. This could put pressure on the stock and force the price higher. It could become a self-fulfilling prophecy.

The lower part of the chart is the Relative Strength Index (RSI) momentum indicator. When the blue line crosses below the horizontal red line, it indicates oversold conditions. As you can see, that is the case now. Pfizer is very oversold.

There is also another reason why the stock may reverse and head higher.

The shares have dropped to a price level that was support in April. Stocks tend to have support at levels that had been support before. Sometimes they can even rally off of support.

There are traders and investors who sold at the support level in April and regretted doing so when the price moved higher. Some decide to buy their shares back if they can at the same price they were sold.

So, now that the shares are back to their selling price, they are placing buy orders. This creates support.

The combination of being oversold and at support means there is a good chance Pfizer reverses and heads higher.

Read Next:
• Just Before Biden’s Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants

Photo: Shutterstock

Continue Reading...

Popular

Denmark eyes new law to protect citizens from AI deepfakes

COPENHAGEN, Denmark (AP) — In 2021, Danish video game live-streamer Marie Watson received an image of herself from an unknown Instagram account.

Denmark's government aims to ban access to social media for children aged under 15

COPENHAGEN, Denmark (AP) — Denmark’s government on Friday announced a political agreement to ban access to social media for anyone aged under 15.

"The Next Industrial Revolution Has Begun" - Ad

Autonomous vehicles... Military drones... AI-powered factories... This is bigger than ChatGPT. And they all rely on this one product. Get in before the next wave of contracts and government funding hits.

Embed-Graphic-Musk-Pay Package-Explainer, ADVISORY

MUSK-PAY PACKAGE-EXPLAINER — Graphic. Elon Musk turned off potential buyers of his Tesla cars and sent sales plunging by spouting off about politics, but he says the company can’t do without him and should pay him more — a lot more. The following digital embed shows the milestones required for Elon Musk to receive a desired $1 trillion pay package from Tesla. This graphic is current as of Nov. 4, 2025 and will not update. Source: Tesla; FactSet

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

Trump Says Biden Was 'Vicious On Crypto' But He's Ended The 'War' On The Industry: 'It Was Terrible'

President Donald Trump reiterated his support for the cryptocurrency industry on Wednesday, adding that the asset class takes significant pressure off the dollar.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Anthony Scaramucci Calls Zohran Mamdani's Win An 'Anger-Based Reaction' To Boomer Policies, Says New NYC Mayor Could Become 'Popular' If...

Anthony Scaramucci, the founder of SkyBridge Capital, described Zohran Mamdani’s victory in New York City's mayoral race as an “anger-based reaction” by the young people against the policies of the boomer generation's political elites.

Attackers board a ship off the coast of Somalia after firing rocket-propelled grenades

DUBAI, United Arab Emirates (AP) — Attackers firing machine guns and rocket-propelled grenades boarded a ship off the coast of on Thursday, British officials said, likely the latest assault by resurgent Somali pirates operating in the region.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad

Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.

SoftBank CEO: "This is the Golden Age" - Ad

AI is no longer stuck in screens. It's entering the real world. We call it "Embodied Intelligence" - or E.I. or short. And three stocks stand to gain the most from this movement. They're already landing contracts in defense, robotics, and automation... And Wall Street is just waking up.

Jim Cramer Warns 'Don't Be Fooled' Because Speculators In Gold, Quantum And Nuclear Energy Aren't Going Down 'Without A Fight'

Former hedge fund manager and renowned CNBC TV host Jim Cramer is sounding the alarm on certain speculative pockets of the market, urging investors to sell into the "snapback" momentum if they haven't already done so.

ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday

Key stocks to watch include Williams Companies, Spirit AeroSystems, Goodyear Tire & Rubber, IDEXX Laboratories, and ON Semiconductor

Is This Nvidia's Next Big Invention? (Picture Inside) - Ad

Write these three letters down: Q.P.U. According to Bank of America... This new tech could be the biggest revolution for humanity since discovering fire. It could change everything.

Donald Trump Jr.-Linked Drone Maker Unusual Machines Wins Major Pentagon Deal

Unusual Machines secures its largest Pentagon drone contract to date, with Trump Jr. serving as an adviser but not involved in the deal.

Peter Schiff Warns Inflation Is 'Not Dead,' Says Prices Under Trump Will Run Hotter Than Biden

Economist Peter Schiff has pushed back against President Donald Trump for claiming victory over inflation, even as price pressures continue to persist in the broader economy.

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys

Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Other key trades were also made, including buying shares in CRISPR and Beam Therapeutics.

Musk the trillionaire? Debate over his Tesla pay package rages

NEW YORK (AP) — Elon Musk turned off many potential buyers of his Tesla cars and sent sales plunging with his . But the stock has soared anyway and now he wants the company to pay him more — a lot more.

Is Musk Really Creating a Robot Army? - Ad

Machines that move. Think. Act on their own. This is the rise of Embodied Intelligence - and it's bigger than AI. Tesla, NVIDIA, and Amazon are already spending billions. But we think this stock could soar even greater.

Norway transport firm steps up controls after tests show Chinese-made buses can be halted remotely

OSLO, Norway (AP) — A leading Norwegian public transport operator has said it will introduce stricter security requirements and step up anti-hacking measures after a test on new Chinese-made electric buses showed the manufacturer could remotely turn them off.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending

Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.

San Francisco mayor proposes denser housing to tackle affordability crisis

SAN FRANCISCO (AP) — San Francisco Mayor Daniel Lurie is trying to get more homes built for people like Liam Murphy: a fifth-generation city kid who found himself repeatedly outbid for tiny two-bedroom houses that wound up selling for $1.6 million.

"The Next Industrial Revolution Has Begun" - Ad

Autonomous vehicles... Military drones... AI-powered factories... This is bigger than ChatGPT. And they all rely on this one product. Get in before the next wave of contracts and government funding hits.

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Why Is Phio Pharmaceuticals Stock Soaring Today?

Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.

Instacart Powers Grubhub's Grocery Blitz Across America

Grubhub taps Instacart for nationwide grocery ordering, with Instacart fulfillment, pharmacy additions coming, and promos boosting adoption despite CART dip.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Nvidia, TSMC Unveil The First US-Made Blackwell Wafer, But Analyst Ming-Chi Kuo Flags This Overlooked Detail

Nvidia Corp (NASDAQ: NVDA) has introduced the first U.S.-made Blackwell wafer, a crucial component for AI chips, at Taiwan Semiconductor Manufacturing Co's (NYSE: TSM) facility in Phoenix.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service